Justin Hayes is the founder and CEO of Concordance Therapeutics. He is in the last months of his Ph.D. at Northeastern University (Boston, MA) where he spun out Concordance Therapeutics from his doctoral research. Hayes has >4 years of experience in metabolic engineering and synthetic biology for applications in the gastrointestinal tract.